Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v1-EN
Language French English
Date Updated 2024-08-08 2024-03-22
Drug Identification Number 02504545 02504545
Brand name PHENYLEPHRINE HYDROCHLORIDE INJECTION USP PHENYLEPHRINE HYDROCHLORIDE INJECTION USP
Common or Proper name PHENYLEPHRINE HYDROCHLORIDE INJECTION USP PHENYLEPHRINE HYDROCHLORIDE INJECTION USP
Company Name STERIMAX INC STERIMAX INC
Ingredients PHENYLEPHRINE HYDROCHLORIDE PHENYLEPHRINE HYDROCHLORIDE
Strength(s) 10MG 10MG
Dosage form(s) SOLUTION SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR
Packaging size 25 VIALS 1 ML 25 VIALS 1 ML
ATC code C01CA C01CA
ATC description CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2024-03-22 2024-03-22
Actual discontinuation date 2024-07-30
Remaining supply date 2024-03-22 2024-03-22
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments